Capital Advisors Ltd’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Hold |
149
| – | – | ﹤0.01% | 932 |
|
|
2025
Q1 | $5K | Hold |
149
| – | – | ﹤0.01% | 924 |
|
|
2024
Q4 | $4K | Sell |
149
-65
| -30% | -$1.75K | ﹤0.01% | 976 |
|
|
2024
Q3 | $6K | Hold |
214
| – | – | ﹤0.01% | 895 |
|
|
2024
Q2 | $6K | Sell |
214
-143
| -40% | -$4.01K | ﹤0.01% | 887 |
|
|
2024
Q1 | $11K | Buy |
357
+158
| +79% | +$4.87K | ﹤0.01% | 701 |
|
|
2023
Q4 | $6K | Sell |
199
-97
| -33% | -$2.93K | ﹤0.01% | 804 |
|
|
2023
Q3 | $8K | Buy |
296
+82
| +38% | +$2.22K | ﹤0.01% | 726 |
|
|
2023
Q2 | $7K | Buy |
214
+180
| +529% | +$5.89K | ﹤0.01% | 762 |
|
|
2023
Q1 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 1102 |
|
|
2022
Q4 | – | Sell |
-9
| Closed | – | – | 1575 |
|
|
2022
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1476 |
|
|
2022
Q2 | – | Sell |
-22
| Closed | -$1K | – | 1280 |
|
|
2022
Q1 | $1K | Buy |
22
+16
| +267% | +$727 | ﹤0.01% | 793 |
|
|
2021
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 918 |
|